We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · January 04, 2021

Thromboembolism Risk in Patients With ALK- and EGFR-Mutant Lung Cancer

Journal of Thrombosis and Haemostasis (JTH)


Additional Info

Journal of Thrombosis and Haemostasis (JTH)
Risk of Thromboembolism in Patients With ALK and EGFR-Mutant Lung Cancer: A Cohort Study
J. Thromb. Haemost. 2020 Dec 14;[EPub Ahead of Print], J Roopkumar, SK Poudel, L Gervaso, CA Reddy, V Velcheti, NA Pennell, KR McCrae, AA Khorana

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading